1
|
Carbone NA, Vera DA, Iriarte DI, Pomarico JA, Macdonald R, Grosenick D. Camera-based CW Diffuse Optical Tomography for obtaining 3D absorption maps by means of digital tomosynthesis. Biomed Phys Eng Express 2020; 6. [PMID: 35039466 DOI: 10.1088/2057-1976/abc633] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Accepted: 10/30/2020] [Indexed: 11/11/2022]
Abstract
We present a novel method for obtaining a 3D absorption map of a tissue-like turbid slab in the near-infrared spectral range by tomosynthesis. Transmittance data are obtained for a large number of oblique projection directions by scanning a cw laser source across the surface of the slab and by using a CCD camera for spatially resolved light detection. A perturbation model of light transport is used to convert the intensity maps for the different projections into absorption maps. By applying the tomosynthesis approach to these new maps, 3D absorption information on embedded inclusions has been obtained for the first time. The number and the positions of the lateral offset detectors have been optimized by employing a structural similarity index for comparison of the reconstructed with the true absorption data. We present 3D reconstruction of absorption maps using both Monte Carlo simulations and experiments on phantoms with breast-like optical properties. A comparison with conventional 3D reconstruction by a finite element approach shows the superior location performance of tomosynthesis.
Collapse
Affiliation(s)
- N A Carbone
- CIFICEN (UNCPBA-CONICET-CICPBA), Pinto 399, B7000GHG Tandil, Argentina
| | - D A Vera
- CIFICEN (UNCPBA-CONICET-CICPBA), Pinto 399, B7000GHG Tandil, Argentina
| | - D I Iriarte
- CIFICEN (UNCPBA-CONICET-CICPBA), Pinto 399, B7000GHG Tandil, Argentina
| | - J A Pomarico
- CIFICEN (UNCPBA-CONICET-CICPBA), Pinto 399, B7000GHG Tandil, Argentina
| | - R Macdonald
- Physikalisch-Technische Bundesanstalt (PTB), Abbestraße 2-12, 10587 Berlin, Germany
| | - D Grosenick
- Physikalisch-Technische Bundesanstalt (PTB), Abbestraße 2-12, 10587 Berlin, Germany
| |
Collapse
|
2
|
Forgách L, Hegedűs N, Horváth I, Kiss B, Kovács N, Varga Z, Jakab G, Kovács T, Padmanabhan P, Szigeti K, Máthé D. Fluorescent, Prussian Blue-Based Biocompatible Nanoparticle System for Multimodal Imaging Contrast. NANOMATERIALS 2020; 10:nano10091732. [PMID: 32878344 PMCID: PMC7557721 DOI: 10.3390/nano10091732] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Revised: 08/21/2020] [Accepted: 08/27/2020] [Indexed: 02/06/2023]
Abstract
(1) Background. The main goal of this work was to develop a fluorescent dye-labelling technique for our previously described nanosized platform, citrate-coated Prussian blue (PB) nanoparticles (PBNPs). In addition, characteristics and stability of the PB nanoparticles labelled with fluorescent dyes were determined. (2) Methods. We adsorbed the fluorescent dyes Eosin Y and Rhodamine B and methylene blue (MB) to PB-nanoparticle systems. The physicochemical properties of these fluorescent dye-labeled PBNPs (iron(II);iron(III);octadecacyanide) were determined using atomic force microscopy, dynamic light scattering, zeta potential measurements, scanning- and transmission electron microscopy, X-ray diffraction, and Fourier-transformation infrared spectroscopy. A methylene-blue (MB) labelled, polyethylene-glycol stabilized PBNP platform was selected for further assessment of in vivo distribution and fluorescent imaging after intravenous administration in mice. (3) Results. The MB-labelled particles emitted a strong fluorescent signal at 662 nm. We found that the fluorescent light emission and steric stabilization made this PBNP-MB particle platform applicable for in vivo optical imaging. (4) Conclusion. We successfully produced a fluorescent and stable, Prussian blue-based nanosystem. The particles can be used as a platform for imaging contrast enhancement. In vivo stability and biodistribution studies revealed new aspects of the use of PBNPs.
Collapse
Affiliation(s)
- László Forgách
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085 Budapest, Hungary; (N.H.); (I.H.); (B.K.); (N.K.); (Z.V.)
- Correspondence: (L.F.); (K.S.); (D.M.); Tel.: +36-1-459-1500 (ext. 60164) (L.F.); +36-1-459-1500 (ext. 60210) (D.M.)
| | - Nikolett Hegedűs
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085 Budapest, Hungary; (N.H.); (I.H.); (B.K.); (N.K.); (Z.V.)
| | - Ildikó Horváth
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085 Budapest, Hungary; (N.H.); (I.H.); (B.K.); (N.K.); (Z.V.)
| | - Bálint Kiss
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085 Budapest, Hungary; (N.H.); (I.H.); (B.K.); (N.K.); (Z.V.)
| | - Noémi Kovács
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085 Budapest, Hungary; (N.H.); (I.H.); (B.K.); (N.K.); (Z.V.)
| | - Zoltán Varga
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085 Budapest, Hungary; (N.H.); (I.H.); (B.K.); (N.K.); (Z.V.)
- Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, 1117 Budapest, Hungary
| | - Géza Jakab
- Department of Pharmaceutics, Semmelweis University, 1085 Budapest, Hungary;
| | - Tibor Kovács
- Institute of Radiochemistry and Radioecology, University of Pannonia, 8200 Veszprém, Hungary;
| | - Parasuraman Padmanabhan
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 636921, Singapore;
| | - Krisztián Szigeti
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085 Budapest, Hungary; (N.H.); (I.H.); (B.K.); (N.K.); (Z.V.)
- Correspondence: (L.F.); (K.S.); (D.M.); Tel.: +36-1-459-1500 (ext. 60164) (L.F.); +36-1-459-1500 (ext. 60210) (D.M.)
| | - Domokos Máthé
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085 Budapest, Hungary; (N.H.); (I.H.); (B.K.); (N.K.); (Z.V.)
- In Vivo Imaging Advanced Core Facility, Hungarian Centre of Excellence for Molecular Medicine, 6723 Szeged, Hungary
- CROmed Translational Research Centers, 1047 Budapest, Hungary
- Correspondence: (L.F.); (K.S.); (D.M.); Tel.: +36-1-459-1500 (ext. 60164) (L.F.); +36-1-459-1500 (ext. 60210) (D.M.)
| |
Collapse
|
3
|
Baikejiang R, Zhang W, Li C. Diffuse optical tomography for breast cancer imaging guided by computed tomography: A feasibility study. JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY 2017; 25:341-355. [PMID: 27983569 DOI: 10.3233/xst-16183] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
Diffuse optical tomography (DOT) has attracted attentions in the last two decades due to its intrinsic sensitivity in imaging chromophores of tissues such as hemoglobin, water, and lipid. However, DOT has not been clinically accepted yet due to its low spatial resolution caused by strong optical scattering in tissues. Structural guidance provided by an anatomical imaging modality enhances the DOT imaging substantially. Here, we propose a computed tomography (CT) guided multispectral DOT imaging system for breast cancer imaging. To validate its feasibility, we have built a prototype DOT imaging system which consists of a laser at the wavelength of 650 nm and an electron multiplying charge coupled device (EMCCD) camera. We have validated the CT guided DOT reconstruction algorithms with numerical simulations and phantom experiments, in which different imaging setup parameters, such as projection number of measurements and width of measurement patch, have been investigated. Our results indicate that an air-cooling EMCCD camera is good enough for the transmission mode DOT imaging. We have also found that measurements at six angular projections are sufficient for DOT to reconstruct the optical targets with 2 and 4 times absorption contrast when the CT guidance is applied. Finally, we have described our future research plan on integration of a multispectral DOT imaging system into a breast CT scanner.
Collapse
|
4
|
Kim MJ, Su MY, Yu HJ, Chen JH, Kim EK, Moon HJ, Choi JS. US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers. BMC Cancer 2016; 16:50. [PMID: 26833069 PMCID: PMC4736271 DOI: 10.1186/s12885-016-2086-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Accepted: 01/27/2016] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND To correlate parameters of Ultrasonography-guided Diffuse optical tomography (US-DOT) with pharmacokinetic features of Dynamic contrast-enhanced (DCE)-MRI and pathologic markers of breast cancer. METHODS Our institutional review board approved this retrospective study and waived the requirement for informed consent. Thirty seven breast cancer patients received US-DOT and DCE-MRI with less than two weeks in between imaging sessions. The maximal total hemoglobin concentration (THC) measured by US-DOT was correlated with DCE-MRI pharmacokinetic parameters, which included K(trans), k ep and signal enhancement ratio (SER). These imaging parameters were also correlated with the pathologic biomarkers of breast cancer. RESULTS The parameters THC and SER showed marginal positive correlation (r = 0.303, p = 0.058). Tumors with high histological grade, negative ER, and higher Ki-67 expression ≥ 20% showed statistically higher THC values compared to their counterparts (p = 0.019, 0.041, and 0.023 respectively). Triple-negative (TN) breast cancers showed statistically higher K(trans) values than non-TN cancers (p = 0.048). CONCLUSION THC obtained from US-DOT and K(trans) obtained from DCE-MRI were associated with biomarkers indicative of a higher aggressiveness in breast cancer. Although US-DOT and DCE-MRI both measured the vascular properties of breast cancer, parameters from the two imaging modalities showed a weak association presumably due to their different contrast mechanisms and depth sensitivities.
Collapse
Affiliation(s)
- Min Jung Kim
- Department of Radiology, Breast Cancer Clinic, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, South Korea. .,Department of Radiological Sciences, University of California, Irvine, CA, USA.
| | - Min-Ying Su
- Department of Radiological Sciences, University of California, Irvine, CA, USA.
| | - Hon J Yu
- Department of Radiological Sciences, University of California, Irvine, CA, USA.
| | - Jeon-Hor Chen
- Department of Radiological Sciences, University of California, Irvine, CA, USA. .,Department of Radiology, Eda Hospital and I-Shou University, Kaohsiung, Taiwan.
| | - Eun-Kyung Kim
- Department of Radiology, Breast Cancer Clinic, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, South Korea.
| | - Hee Jung Moon
- Department of Radiology, Breast Cancer Clinic, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, South Korea.
| | - Ji Soo Choi
- Department of Radiology, Breast Cancer Clinic, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, South Korea. .,Department of Radiology, Samsung Medical Center, Seoul, Korea.
| |
Collapse
|
5
|
Erickson-Bhatt SJ, Roman M, Gonzalez J, Nunez A, Kiszonas R, Lopez-Penalver C, Godavarty A. Noninvasive Surface Imaging of Breast Cancer in Humans using a Hand-held Optical Imager. Biomed Phys Eng Express 2015; 1. [PMID: 27366327 DOI: 10.1088/2057-1976/1/4/045001] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
X-ray mammography, the current gold standard for breast cancer detection, has a 20% false-negative rate (cancer is undetected) and increases in younger women with denser breast tissue. Diffuse optical imaging (DOI) is a safe (nonionizing), and relatively inexpensive method for noninvasive imaging of breast cancer in human subjects (including dense breast tissues) by providing physiological information (e.g. oxy- and deoxy- hemoglobin concentration). At the Optical Imaging Laboratory, a hand-held optical imager has been developed which employs a breast contourable probe head to perform simultaneous illumination and detection of large surfaces towards near real-time imaging of human breast cancer. Gen-1 and gen-2 versions of the handheld optical imager have been developed and previously demonstrated imaging in tissue phantoms and healthy human subjects. Herein, the hand-held optical imagers are applied towards in vivo imaging of breast cancer subjects in an attempt to determine the ability of the imager to detect breast tumors. Five female human subjects (ages 51-74) diagnosed with breast cancer were imaged with the gen-1 optical imager prior to surgical intervention. One of the subjects was also imaged with the gen-2 optical imager. Both imagers use 785 nm laser diode sources and ICCD camera detectors to generate 2D surfaces maps of total hemoglobin absorption. The subjects lay in supine position and images were collected at various locations on both the ipsilateral (tumor-containing) and contralateral (non-tumor containing) breasts. The optical images (2D surface maps of optical absorption due to total hemoglobin concentration) show regions of higher intensity at the tumor location, which is indicative of increased vasculature and higher blood content due to the presence of the tumor. Additionally, a preliminary result indicates the potential to image lymphatic spread. This study demonstrates the potential of the hand-held optical devices to noninvasively image breast cancer in human subjects.
Collapse
Affiliation(s)
- Sarah J Erickson-Bhatt
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| | - Manuela Roman
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| | - Jean Gonzalez
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| | - Annie Nunez
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| | - Richard Kiszonas
- Dept. of Breast Radiology, Sylvester Comprehensive Cancer Center, 1475 N.W. 12th Ave., Miami, FL, USA 33136
| | | | - Anuradha Godavarty
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| |
Collapse
|
6
|
Rühm A, Göbel W, Sroka R, Stepp H. ICG-assisted blood vessel detection during stereotactic neurosurgery: Simulation study on excitation power limitations due to thermal effects in human brain tissue. Photodiagnosis Photodyn Ther 2014; 11:307-18. [DOI: 10.1016/j.pdpdt.2014.03.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2013] [Revised: 03/08/2014] [Accepted: 03/11/2014] [Indexed: 11/16/2022]
|
7
|
Erickson SJ, Martinez SL, DeCerce J, Romero A, Caldera L, Godavarty A. Three-dimensional fluorescence tomography of human breast tissues in vivo using a hand-held optical imager. Phys Med Biol 2013; 58:1563-79. [PMID: 23417060 DOI: 10.1088/0031-9155/58/5/1563] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Diffuse optical imaging using non-ionizing radiation is a non-invasive method that shows promise towards breast cancer diagnosis. Hand-held optical imagers show potential for clinical translation of the technology, yet they have not been used towards 3D tomography. Herein, 3D tomography of human breast tissue in vivo is demonstrated for the first time using a hand-held optical imager with automated coregistration facilities. Simulation studies are performed on breast geometries to demonstrate the feasibility of 3D tomographic imaging using a hand-held imager under perfect (1:0) and imperfect (100:1, 50:1) fluorescence absorption contrast ratios. Experimental studies are performed in vivo using a 1 µM ICG filled phantom target placed non-invasively underneath the flap of the breast tissue. Results show the ability to perform automated tracking and coregistered imaging of human breast tissue (with tracking accuracy on the order of ∼1 cm). Three-dimensional tomography results demonstrated the ability to recover a single target placed at a depth of 2.5 cm, from both the simulated (at 1:0, 100:1 and 50:1 contrasts) and experimental cases on actual breast tissues. Ongoing efforts to improve target depth recovery are carried out via implementation of transmittance imaging in the hand-held imager.
Collapse
Affiliation(s)
- Sarah J Erickson
- Department of Biomedical Engineering, Florida International University, 10555 West Flagler Street EC 2610, Miami, FL 33174, USA
| | | | | | | | | | | |
Collapse
|
8
|
Zhang W, Wu L, Li J, Yi X, Wang X, Lu Y, Chen W, Zhou Z, Zhang L, Zhao H, Gao F. Combined hemoglobin and fluorescence diffuse optical tomography for breast tumor diagnosis: a pilot study on time-domain methodology. BIOMEDICAL OPTICS EXPRESS 2013; 4:331-48. [PMID: 23412647 PMCID: PMC3567719 DOI: 10.1364/boe.4.000331] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2012] [Revised: 01/21/2013] [Accepted: 01/23/2013] [Indexed: 05/14/2023]
Abstract
A combined time-domain fluorescence and hemoglobin diffuse optical tomography (DOT) system and the image reconstruction methods are proposed for enhancing the reliability of breast-dedicated optical measurement. The system equipped with two pulsed laser diodes at wavelengths of 780 nm and 830 nm that are specific to the peak excitation and emission of the FDA-approved ICG agent, and works with a 4-channel time-correlated single photon counting device to acquire the time-resolved distributions of the light re-emissions at 32 boundary sites of tissues in a tandem serial-to-parallel mode. The simultaneous reconstruction of the two optical (absorption and scattering) and two fluorescent (yield and lifetime) properties are achieved with the respective featured-data algorithms based on the generalized pulse spectrum technique. The performances of the methodology are experimentally assessed on breast-mimicking phantoms for hemoglobin- and fluorescence-DOT alone, as well as for fluorescence-guided hemoglobin-DOT. The results demonstrate the efficacy of improving the accuracy of hemoglobin-DOT based on a priori fluorescence localization.
Collapse
Affiliation(s)
- Wei Zhang
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
| | - Linhui Wu
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
| | - Jiao Li
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
| | - Xi Yi
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
| | - Xin Wang
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
| | - Yiming Lu
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
| | - Weiting Chen
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
| | - Zhongxing Zhou
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
- Tianjin Key Laboratory of Biomedical Detecting Techniques and Instruments, Tianjin 300072, China
| | - Limin Zhang
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
- Tianjin Key Laboratory of Biomedical Detecting Techniques and Instruments, Tianjin 300072, China
| | - Huijuan Zhao
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
- Tianjin Key Laboratory of Biomedical Detecting Techniques and Instruments, Tianjin 300072, China
| | - Feng Gao
- College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China
- Tianjin Key Laboratory of Biomedical Detecting Techniques and Instruments, Tianjin 300072, China
| |
Collapse
|
9
|
Adams A, Mourik JEM, van der Voort M, Pearlman PC, Nielsen T, Mali WPTM, Elias SG. Estimation of detection limits of a clinical fluorescence optical mammography system for the near-infrared fluorophore IRDye800CW: phantom experiments. JOURNAL OF BIOMEDICAL OPTICS 2012; 17:076022. [PMID: 22894505 DOI: 10.1117/1.jbo.17.7.076022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
To evaluate if clinical fluorescence imaging of IRDye800CW is feasible on our fluorescence optical mammography system by estimating detection limits assessed by breast-cancer-simulating phantom experiments. Phantoms (2.1 cm(3), 0.9 cm(3)) with IRDye800CW concentrations of 0.5 to 120 nM were suspended in a 550 cm(3) measurement cup containing 507 surface-mounted source and detector fibers. The cup was filled with optical matching fluid containing IRDye800CW concentrations of 0, 5, 10, or 20 nM. Tomographic fluorescence images were acquired by exciting IRDye800CW at 730 nm; wavelengths above 750 nm were filtered. Signal intensities were calculated over a volume of interest corresponding to the size and location of the phantom in the reconstructed images. Correlations (R(2)) were calculated, and detection limits with associated upper 95% prediction interval were estimated. Between-day reproducibility was assessed with intraclass correlation coefficients (ICC). Fluorescent intensities were strongly correlated with phantom IRDye800CW concentrations (R(2)0.983 to 0.999). IRDye800CW detection limits ranged from 0.14 to 2.46 nM (upper 95% prediction limit 4.63 to 18.63 nM). ICC ranged from 0.88 to 1.00. The estimated detection limits for IRDye800CW were in the low-nanomolar range. These results support the start of clinical trials to evaluate the fluorescence optical mammography system using IRDye800CW labeled breast cancer targeting ligands.
Collapse
Affiliation(s)
- Arthur Adams
- University Medical Center Utrecht, Department of Radiology, Utrecht, The Netherlands.
| | | | | | | | | | | | | |
Collapse
|
10
|
Heijblom M, Piras D, Xia W, van Hespen JCG, Klaase JM, van den Engh FM, van Leeuwen TG, Steenbergen W, Manohar S. Visualizing breast cancer using the Twente photoacoustic mammoscope: what do we learn from twelve new patient measurements? OPTICS EXPRESS 2012; 20:11582-97. [PMID: 22714144 DOI: 10.1364/oe.20.011582] [Citation(s) in RCA: 115] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
We acquired images of breast malignancies using the Twente photoacoustic mammoscope (PAM), to obtain more information about the clinical feasibility and limitations of photoacoustic mammography. Results were compared with conventional imaging and histopathology. Ten technically acceptable measurements on patients with malignancies and two measurements on patients with cysts were performed. In the reconstructed volumes of all ten malignant lesions, a confined region with high contrast with respect to the background could be seen. In all malignant cases, the PA contrast of the abnormality was higher than the contrast on x-ray mammography. The PA contrast appeared to be independent of the mammographically estimated breast density and was absent in the case of cysts. Technological improvements to the instrument and further studies on less suspicious lesions are planned to further investigate the potential of PAM.
Collapse
Affiliation(s)
- M Heijblom
- Biomedical Photonic Imaging Group, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, the Netherlands.
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Lanzardo S, Conti L, Brioschi C, Bartolomeo MP, Arosio D, Belvisi L, Manzoni L, Maiocchi A, Maisano F, Forni G. A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts. CONTRAST MEDIA & MOLECULAR IMAGING 2012; 6:449-58. [PMID: 22144022 DOI: 10.1002/cmmi.444] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
α(V)β(3) Integrins are a widely recognized target for in vivo molecular imaging of pathological conditions such as inflammation, cancer and rheumatoid arthritis. We have evaluated the sensitivity of a new, near-infrared fluorescence (NIRF), RGD cyclic probe (DA364) in noninvasive detection of α(V) β(3) integrin-overexpressing tumors. DA364's binding affinity for α(V)β(3) integrin was first evaluated in vitro. Human α(V)β(3) integrin-positive, U-87 MG glioblastoma cells were then xenografted in nude mice, and DA364 was injected intravenously (i.v.) to evaluate its in vivo distribution, specificity and sensitivity in comparison with a commercially available probe. DA364 bound α(V)β(3) integrin on U-87 MG cells with high affinity and specificity, both in vitro and in vivo. This binding specificity was corroborated by the strong inhibition of its tumor uptake induced by nonfluorescent, cyclic-RGD peptides. Ex vivo analysis showed that DA364 accumulated at the tumor site, whereas very low levels were detected in liver and spleen. In conclusion, DA364 allows sensitive and specific detection of transplantable glioblastoma by NIRF imaging, and is thus a promising candidate for the elaboration of imaging and therapeutic probes for α(V)β(3) integrin-overexpressing tumors.
Collapse
Affiliation(s)
- Stefania Lanzardo
- Molecular Biotechnology Center, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
van de Ven SMWY, Elias SG, Chan CT, Miao Z, Cheng Z, De A, Gambhir SS. Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model. Clin Cancer Res 2012; 18:1073-81. [PMID: 22235098 DOI: 10.1158/1078-0432.ccr-10-3213] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
PURPOSE To determine whether optical imaging can be used for in vivo therapy response monitoring as an alternative to radionuclide techniques. For this, we evaluated the known Her2 response to 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride (17-DMAG) treatment, an Hsp90 inhibitor. EXPERIMENTAL DESIGN After in vitro 17-DMAG treatment response evaluation of MCF7 parental cells and 2 HER2-transfected clones (clone A medium, B high Her2 expression), we established human breast cancer xenografts in nude mice (only parental and clone B) for in vivo evaluation. Mice received 120 mg/kg of 17-DMAG in 4 doses at 12-hour intervals intraperitonially (n = 14) or PBS as carrier control (n = 9). Optical images were obtained both pretreatment (day 0) and posttreatment (day 3, 6, and 9), always 5 hours postinjection of 500 pmol of anti-Her2 Affibody-AlexaFluor680 via tail vein (with preinjection background subtraction). Days 3 and 9 in vivo optical imaging signal was further correlated with ex vivo Her2 levels by Western blot after sacrifice. RESULTS Her2 expression decreased with 17-DMAG dose in vitro. In vivo optical imaging signal was reduced by 22.5% in clone B (P = 0.003) and by 9% in MCF7 parental tumors (P = 0.23) 3 days after 17-DMAG treatment; optical imaging signal recovered in both tumor types at days 6 to 9. In the carrier group, no signal reduction was observed. Pearson correlation of in vivo optical imaging signal with ex vivo Her2 levels ranged from 0.73 to 0.89. CONCLUSIONS Optical imaging with an affibody can be used to noninvasively monitor changes in Her2 expression in vivo as a response to treatment with an Hsp90 inhibitor, with results similar to response measurements in positron emission tomography imaging studies.
Collapse
|
13
|
Heijblom M, Klaase JM, van den Engh FM, van Leeuwen TG, Steenbergen W, Manohar S. Imaging Tumor Vascularization for Detection and Diagnosis of Breast Cancer. Technol Cancer Res Treat 2011; 10:607-23. [DOI: 10.7785/tcrt.2012.500227] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Affiliation(s)
- M. Heijblom
- Biomedical Photonic Imaging Group, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE Enschede, the Netherlands
- Center for Breast Care, Medisch Spectrum Twente Hospital, P.O. Box 50000, 7500 KA Enschede, the Netherlands
| | - J. M. Klaase
- Center for Breast Care, Medisch Spectrum Twente Hospital, P.O. Box 50000, 7500 KA Enschede, the Netherlands
| | - F. M. van den Engh
- Center for Breast Care, Medisch Spectrum Twente Hospital, P.O. Box 50000, 7500 KA Enschede, the Netherlands
| | - T. G. van Leeuwen
- Biomedical Photonic Imaging Group, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE Enschede, the Netherlands
- Biomedical Engineering and Physics, Academic Medical Center, University of Amsterdam, P.O. Box 2270, 1100 DE Amsterdam, the Netherlands
| | - W. Steenbergen
- Biomedical Photonic Imaging Group, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE Enschede, the Netherlands
| | - S. Manohar
- Biomedical Photonic Imaging Group, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE Enschede, the Netherlands
| |
Collapse
|
14
|
Collettini F, Martin JC, Diekmann F, Fallenberg E, Engelken F, Ponder S, Kroencke TJ, Hamm B, Poellinger A. Diagnostic performance of a near-infrared breast imaging system as adjunct to mammography versus X-ray mammography alone. Eur Radiol 2011; 22:350-7. [DOI: 10.1007/s00330-011-2276-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2011] [Revised: 06/25/2011] [Accepted: 07/20/2011] [Indexed: 10/17/2022]
|
15
|
Flexman ML, Khalil MA, Al Abdi R, Kim HK, Fong CJ, Desperito E, Hershman DL, Barbour RL, Hielscher AH. Digital optical tomography system for dynamic breast imaging. JOURNAL OF BIOMEDICAL OPTICS 2011; 16:076014. [PMID: 21806275 PMCID: PMC3273311 DOI: 10.1117/1.3599955] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2011] [Revised: 05/19/2011] [Accepted: 05/23/2011] [Indexed: 05/18/2023]
Abstract
Diffuse optical tomography has shown promising results as a tool for breast cancer screening and monitoring response to chemotherapy. Dynamic imaging of the transient response of the breast to an external stimulus, such as pressure or a respiratory maneuver, can provide additional information that can be used to detect tumors. We present a new digital continuous-wave optical tomography system designed to simultaneously image both breasts at fast frame rates and with a large number of sources and detectors. The system uses a master-slave digital signal processor-based detection architecture to achieve a dynamic range of 160 dB and a frame rate of 1.7 Hz with 32 sources, 64 detectors, and 4 wavelengths per breast. Included is a preliminary study of one healthy patient and two breast cancer patients showing the ability to identify an invasive carcinoma based on the hemodynamic response to a breath hold.
Collapse
MESH Headings
- Adult
- Breast/pathology
- Breast Neoplasms/blood supply
- Breast Neoplasms/diagnosis
- Breast Neoplasms/physiopathology
- Carcinoma, Ductal, Breast/blood supply
- Carcinoma, Ductal, Breast/diagnosis
- Carcinoma, Ductal, Breast/physiopathology
- Diagnostic Imaging/instrumentation
- Diagnostic Imaging/methods
- Diagnostic Imaging/statistics & numerical data
- Equipment Design
- Female
- Hemodynamics
- Humans
- Image Processing, Computer-Assisted
- Imaging, Three-Dimensional
- Middle Aged
- Optical Fibers
- Respiratory Mechanics
- Signal Processing, Computer-Assisted
- Tomography, Optical/instrumentation
- Tomography, Optical/methods
- Tomography, Optical/statistics & numerical data
- User-Computer Interface
Collapse
Affiliation(s)
- Molly L Flexman
- Columbia University, Department of Biomedical Engineering, 351 Engineering Terrace, 1210 Amsterdam Avenue, New York, New York 10027, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Luijten PR, Klomp DWJ. High field MRI in clinical practice. DRUG DISCOVERY TODAY. TECHNOLOGIES 2011; 8:e103-e108. [PMID: 24990258 DOI: 10.1016/j.ddtec.2011.11.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Magnetic resonance imaging and spectroscopy can provide detailed morphologic, functional and metabolic information that may provide unique biomarkers to assist drug discovery and development. To overcome the inherent low signal to noise of in vivo magnetic resonance applications, stronger magnetic field strengths can be applied that not only boost signal strengths, but can also be used to improve contrast and specificity as well.:
Collapse
Affiliation(s)
- Peter R Luijten
- University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, Netherlands.
| | - Dennis W J Klomp
- University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, Netherlands
| |
Collapse
|
17
|
Abstract
The process of angiogenesis, an essential hallmark for tumour development as well as for several inflammatory diseases and physiological phenomena, is of growing interest for diagnosis and therapy in oncology. In the context of biochemical characterisation of key molecules involved in angiogenesis, several targets for imaging and therapy could be identified in the last decade. Optical imaging (OI) relies on the visualisation of near infrared (NIR) light, either its absorption and scattering in tissue (non-enhanced OI) or using fluorescent contrast agents. OI offers excellent signal to noise ratios due to virtually absent background fluorescence in the NIR range and is thus a versatile tool to image specific molecular target structures in vivo. This work intends to provide a survey of the different approaches to imaging of angiogenesis using OI methods in preclinical research as well as first clinical trials. Different imaging modalities as well as various optical contrast agents are briefly discussed.
Collapse
|
18
|
Quelles perspectives pour l’imagerie photonique in vivo en pratique clinique ? ONCOLOGIE 2010. [DOI: 10.1007/s10269-010-1862-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
19
|
Kosaka N, Ogawa M, Choyke PL, Kobayashi H. Clinical implications of near-infrared fluorescence imaging in cancer. Future Oncol 2009; 5:1501-11. [PMID: 19903075 PMCID: PMC3413951 DOI: 10.2217/fon.09.109] [Citation(s) in RCA: 121] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Near-infrared (NIR) fluorescence cancer imaging is a growing field for both preclinical and clinical application to the clinical management for cancer patients due to its advantageous features, including a high spatial resolution, portability, real-time display and detailed molecular profiling with the multiplexed use of fluorescent probes. In this review, we present a basic concept of NIR fluorescence imaging and overview its potential clinical applications for in vivo cancer imaging, including cancer detection/characterization, lymphatic imaging (sentinel lymph node detection) and surgical/endoscopic guidance. NIR fluorescence imaging can compensate some limitations of conventional imaging modalities, and thus it could play an important role for cancer imaging combined with other modalities in clinical practice.
Collapse
Affiliation(s)
- Nobuyuki Kosaka
- Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, MD, USA
| | - Mikako Ogawa
- Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, MD, USA
| | - Peter L Choyke
- Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, MD, USA
| | - Hisataka Kobayashi
- Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1B40, MSC1088, Bethesda, MD 20892-1088, USA, Tel.: +1 301 451 4220, Fax: +1 301 402 3191
| |
Collapse
|
20
|
van Esser S, Stapper G, van Diest PJ, van den Bosch MAAJ, Klaessens JHGM, Mali WPTM, Borel Rinkes IHM, van Hillegersberg R. Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol 2009; 16:2259-63. [PMID: 19506958 PMCID: PMC2711908 DOI: 10.1245/s10434-009-0544-z] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2009] [Revised: 05/18/2009] [Accepted: 05/18/2009] [Indexed: 12/19/2022]
Abstract
Background The next step in breast-conserving surgery for small breast carcinomas could be local ablation. In this study, the feasibility of ultrasound-guided laser-induced thermal therapy (LITT) is evaluated. Methods Patients with large-core needle biopsy-proven invasive, palpable breast carcinoma (clinically ≤2 cm) underwent ultrasound-guided LITT, followed by surgical excision. Completeness of ablation was determined by both hematoxylin and eosin staining and nicotinamide adenosine diaphorase staining. Results Fourteen patients completed the treatment. The mean histological tumor size was 17 mm (range, 8–37 mm); 6 of 14 tumors were histologically larger than the clinical entry threshold of 2 cm. The power applied in all patients was 7 W, and the mean treatment time was 21.4 min (range, 15–30 min). In one patient, a skin burn occurred, and one patient had a localized pneumothorax that could be treated conservatively. In 7 (50%) of 14 patients, the tumor was completely ablated, as confirmed by nicotinamide adenosine diaphorase staining. In 11 cases, extensive in-situ carcinoma was present. In one case, the in-situ carcinoma was also completely ablated. A total of seven (88%) of eight tumors <2 cm in size were completely ablated versus one (17%) of six tumors that were ≥2 cm in size (P = .026). Conclusions Successful LITT of invasive breast cancer seems to be feasible when confined to small (<2 cm) nonlobular carcinomas without surrounding extensive in-situ component and angioinvasion. However, to implement LITT in a curative setting, improvements in imaging to more reliably preoperatively assess tumor size and monitoring of fiber tip placement and treatment affect are essential.
Collapse
Affiliation(s)
- S van Esser
- Department of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
| | | | | | | | | | | | | | | |
Collapse
|